• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

IJERPH, Vol. 20, Pages 6107: Pain Self-Management with Inhaled Methoxyflurane by Emergency Department Trauma Patients: A Prospective, Interventional, Single-Center Study
In conclusion, a combination of self-administered methoxyflurane and the WHO analgesic ladder improves pain management in the ED.
Source: International Journal of Environmental Research and Public Health - June 12, 2023 Category: Environmental Health Authors: Daniel Aiham Ghazali Donia Bouzid Alix Frachon Sarah Ait-Abdesselam Philippe Kenway Christophe Choquet Enrique Casalino Tags: Article Source Type: research

Post-COVID condition or “long COVID”, return-to work, and occupational health research
In conclusion, COVID-19 remains an important topic for the occupational health research agenda, including acute and post COVID conditions. Although there is still debate about the definition of what a `post-COVID condition` entails, the sheer number of patients who are not returning to work in a timely manner or returning to work with limitations, and the lack of research interventions available should lead occupational health practitioners and researchers to work not only to prevent infection but to prevent or reduce work disability resulting from the COVID-19 pandemic and future pandemics. Acknowledgements and conflict...
Source: Scandinavian Journal of Work, Environment and Health - March 21, 2023 Category: Occupational Health Tags: Editorial Source Type: research

Weekly Overseas Health IT Links –24th September, 2022.
This article makes the case and explains what will be required to make it happen.We hear a lot about “digital health” these days. As data about our health piles up — thanks to sources like electronic health records, personal fitness apps and gadgets, and home genome test kits — weshould understand a lot more than we used to about what ’s wrong with our health and what to do about it. But having a lot of data is not enough. We have to be aware of what we have, understand what it means, and act on that understanding. While the challenges are in some ways more acute in the United States because of its fragmented sys...
Source: Australian Health Information Technology - September 24, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

Biopsychosocial Factors Predicting Pain among Individuals Experiencing the Novel Coronavirus Disease (COVID-19)
The Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS CoV-2) outbreak that occurred in China in the last months of 2019 has adversely affected the whole world (Nathan, 2020; Shi et al., 2020). This outbreak was named the new type of coronavirus disease (COVID- 19) by the World Health Organization (WHO) and the WHO declared COVID-19 a global pandemic in March of 2020 (A çikgöz& G ünay, 2020; Cucinotta& Vanelli, 2020). The prognosis for COVID-19 disease ranges from asymptomatic infection to multiple organ failure with cardiac, renal, hematological, and neurological effects (Berlin, Gulick,& Martinez, 2020).
Source: Pain Management Nursing - November 16, 2021 Category: Nursing Authors: A. Bilgin, G. Kesik, L. Özdemir Source Type: research

Interventions for palliative symptom control in COVID-19 patients
CONCLUSIONS: We found very low certainty evidence for the efficacy of pharmacological interventions for palliative symptom relief in COVID-19 patients. We found no evidence on the safety of pharmacological interventions or efficacy and safety of non-pharmacological interventions for palliative symptom control in COVID-19 patients. The evidence presented here has no specific implications for palliative symptom control in COVID-19 patients because we cannot draw any conclusions about the effectiveness or safety based on the identified evidence. More evidence is needed to guide clinicians, nursing staff, and caregivers when t...
Source: Cochrane Database of Systematic Reviews - August 23, 2021 Category: General Medicine Authors: Marike Andreas Vanessa Piechotta Nicole Skoetz Kathrin Grummich Marie Becker Lisa Joos Gerhild Becker Winfried Meissner Christopher Boehlke Source Type: research

Rheumatoid arthritis management in the APLAR region: Perspectives from an expert panel of rheumatologists, patients and community oriented program for control of rheumatic diseases
AbstractRheumatoid arthritis (RA) is a major health burden in Asia Pacific affecting the quality of life of patients and consuming healthcare resources. According to recent estimates from the World Health Organization-International League Against Rheumatism-Community Oriented Program for Control of Rheumatic Diseases, prevalence is around 0.3%-0.5%. Management guidelines have helped to improve treatment across this diverse region. To gain better insight into current real-world management applications in view of these guidelines, virtual meetings were conducted in mid-2020 to explore perspectives of rheumatologists and pati...
Source: International Journal of Rheumatic Diseases - August 11, 2021 Category: Rheumatology Authors: Arvind Chopra, Hsiao ‐Yi Lin, Sandra V. Navarra, Muhammad Ahmed Saeed, Sargunan Sockalingam, Supat Thongpooswan, Ramesh Jois, Babur Salim, Ka Wing Gavin Lee, Tang Ching Lau, James Wee Tags: INVITED REVIEW Source Type: research

Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine
NEW BRUNSWICK, N.J., April 21, 2021 – Johnson & Johnson (the Company) today announced publication in the New England Journal of Medicine of primary data from the Phase 3 ENSEMBLE clinical trial for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The publication of the primary analysis follows the topline efficacy and safety data announced in January, showing the trial met all primary and key secondary endpoints, and found that the Johnson & Johnson single-dose COVID-19 vaccine prevented hospitalization and death across all study participants ...
Source: Johnson and Johnson - April 21, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Palliative Care in Toronto during the COVID-19 pandemic
Coronavirus disease 2019 (COVID-19) first emerged in China in December 2019 and was declared a pandemic by the World Health Organization on March 11th, 2020. Clinicians around the world looked to cities that first experienced major surges to inform their preparations to prevent and manage the impact the pandemic would bring to their patients and health care systems. Although this information provided insight into how COVID-19 could affect the Canadian palliative care system, it remained unclear what to expect.
Source: Journal of Pain and Symptom Management - February 4, 2021 Category: Palliative Care Authors: Kirsten Wentlandt, Rose Cook, Matt Morgan, Allyson Nowell, Ebru Kaya, Camilla Zimmermann Tags: Clincal Note Source Type: research

Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a  case report
ConclusionsAmong many potential adverse reactions involving hydroxychloroquine, cutaneous side effects are varied and can lead to significant morbidity or even death. The drug is currently being investigated in a multitude of trials for coronavirus disease2019 treatment, prevention, and prophylaxis after exposure to severe acute respiratory syndrome coronavirus 2. Acute generalized exanthematous pustulosis is a rare side effect of hydroxychloroquine, and even fewer cases demonstrate histologic evidence of acute generalized exanthematous pustulosis while clinically presenting with Stevens-Johnson syndrome. Patients who deve...
Source: Journal of Medical Case Reports - November 3, 2020 Category: General Medicine Source Type: research

Infection Control for COVID-19 Imaging
Discussion: A fear in pandemics is the overwhelming of hospital system capacity by the infected.  As a single confirmed COVID patient can take down a CT or MR suite for anywhere between 1 and 3 hours, depending on whether they are ventilated, this is a reasonable concern. The rate-limiting step in minimizing downtime and enhancing throughput will be air exchange. The following common-sense suggestions may be helpful: First and foremost, PCR is the test of choice for COVID diagnosis. ‘R/O COVID’ using CT is not encouraged. Second, a lot of information can be obtained by a portable chest x-ray. Portable che...
Source: The Health Care Blog - March 26, 2020 Category: Consumer Health News Authors: Christina Liu Tags: COVID-19 Hospitals Medical Practice Physicians coronavirus CT scans Imaging infecton control Pandemic Radiology Stephen Borstelmann Source Type: blogs